Ahmed, H.; Gisler, L.; Elghazawy, N.H.; Keller, C.; Sippl, W.; Liang, S.H.; Haider, A.; Ametamey, S.M.
Development and Validation of [3H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs. Pharmaceuticals 2022, 15, 960.
https://doi.org/10.3390/ph15080960
AMA Style
Ahmed H, Gisler L, Elghazawy NH, Keller C, Sippl W, Liang SH, Haider A, Ametamey SM.
Development and Validation of [3H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs. Pharmaceuticals. 2022; 15(8):960.
https://doi.org/10.3390/ph15080960
Chicago/Turabian Style
Ahmed, Hazem, Livio Gisler, Nehal H. Elghazawy, Claudia Keller, Wolfgang Sippl, Steven H. Liang, Achi Haider, and Simon M. Ametamey.
2022. "Development and Validation of [3H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs" Pharmaceuticals 15, no. 8: 960.
https://doi.org/10.3390/ph15080960
APA Style
Ahmed, H., Gisler, L., Elghazawy, N. H., Keller, C., Sippl, W., Liang, S. H., Haider, A., & Ametamey, S. M.
(2022). Development and Validation of [3H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs. Pharmaceuticals, 15(8), 960.
https://doi.org/10.3390/ph15080960